Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT03054428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Monotherapy in Patients ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
Study identification
- NCT ID
- NCT03054428
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 251 participants
Conditions and interventions
Conditions
Interventions
- Dupilumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2017
- Primary completion
- Apr 3, 2018
- Completion
- Jun 4, 2018
- Last update posted
- Jul 22, 2019
2017 – 2018
United States locations
- U.S. sites
- 36
- U.S. states
- 23
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Regeneron Investigational Site | Birmingham | Alabama | 35209 | — |
| Regeneron Investigational Site | Gilbert | Arizona | 85234 | — |
| Regeneron Investigational Site | Bakersfield | California | 93309 | — |
| Regeneron Investigational Site | Long Beach | California | 90808 | — |
| Regeneron Investigational Site | Rolling Hills Estates | California | 90274 | — |
| Regeneron Investigational Site | San Diego | California | 92123 | — |
| Regeneron Investigational Site | Santa Rosa | California | 95403 | — |
| Regeneron Investigational Site | Centennial | Colorado | 80112 | — |
| Regeneron Investigational Site | Denver | Colorado | 80206 | — |
| Regeneron Investigational Site | Washington D.C. | District of Columbia | 20016 | — |
| Regeneron Investigational Site | Tampa | Florida | 33624 | — |
| Regeneron Investigational Site | Macon | Georgia | 31217 | — |
| Regeneron Investigational Site | Sandy Springs | Georgia | 30328 | — |
| Regeneron Investigational Site | Chicago | Illinois | 60611 | — |
| Regeneron Investigational Site | Evansville | Indiana | 47713 | — |
| Regeneron Investigational Site | Indianapolis | Indiana | 46256 | — |
| Regeneron Investigational Site | Plainfield | Indiana | 46168 | — |
| Regeneron Investigational Site | Rockville | Maryland | 20850 | — |
| Regeneron Investigational Site | Boston | Massachusetts | 02111 | — |
| Regeneron Investigational Site | Boston | Massachusetts | 02115 | — |
| Regeneron Investigational Site | Plymouth | Minnesota | 55441 | — |
| Regeneron Investigational Site | St Louis | Missouri | 63110 | — |
| Regeneron Investigational Site | Forest Hills | New York | 11375 | — |
| Regeneron Investigational Site | New York | New York | 10029 | — |
| Regeneron Investigational Site | Rochester | New York | 14642 | — |
| Regeneron Investigational Site | Chapel Hill | North Carolina | 27516 | — |
| Regeneron Investigational Site | Bexley | Ohio | 43209 | — |
| Regeneron Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Regeneron Investigational Site | Portland | Oregon | 97223 | — |
| Regeneron Investigational Site | Portland | Oregon | 97239 | — |
| Regeneron Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Regeneron Investigational Site | Charleston | South Carolina | 29407 | — |
| Regeneron Investigational Site | Bellaire | Texas | 77401 | — |
| Regeneron Investigational Site | San Antonio | Texas | 78218 | — |
| Regeneron Investigational Site | Norfolk | Virginia | 23502 | — |
| Regeneron Investigational Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03054428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2019 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03054428 live on ClinicalTrials.gov.